Katherine A. Rybinski
Eisai (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Thyroid Cancer Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Cancer Treatment and Pharmacology, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration(2007)151 cited
- → MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity(2018)89 cited
- → Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling(2010)81 cited
- → The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity(2013)54 cited
- → Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature(2015)46 cited
- → Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging(2017)40 cited